Trial Profile
TRIAGE: Patients Undergoing Percutaneous Coronary Interventions to Improve Clinical Outcomes Through Optimal Platelet Inhibition
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2024
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Aspirin; Clopidogrel
- Indications Acute coronary syndromes; Coronary artery disease
- Focus Therapeutic Use
- Acronyms TRIAGE
- 22 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Apr 2012 New trial record